Collaborating to Accelerate COVID-19 Research
From the very start of the novel coronavirus outbreak, STEMCELL Technologies has accelerated the pace of discovery for COVID-19 research. Hear how our Canadian-made products have been used in the effort to develop vaccines and viral treatment.
Publish Date: May 15, 2020
Views: 0
Related Multimedia
-
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016 -
The Peer Review - Documentary Film
Publish Date: July 10, 2018 -
Collaborative Research, Fostering Trust, Advancing Science
Publish Date: May 01, 2019
Explore Our Products
-
EasySep™ Human Custom Enrichment Kit
Immunomagnetic negative selection kit -
SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 (HEK293-expressed)
Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419 -
FRET-based peptide substrate for detection of protease activity of coronaviruses
-
Anti-SARS-CoV Nucleoprotein Antibody, Clone 001 (Recombinant)
Rabbit monoclonal IgG antibody against SARS-CoV, SARS-CoV-2 (2019-nCoV) Nucleoprotein (HEK293-expressed recombinant)